{"id":4390,"date":"2021-05-22T23:06:12","date_gmt":"2021-05-22T23:06:12","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=4390"},"modified":"2021-05-22T23:06:17","modified_gmt":"2021-05-22T23:06:17","slug":"over-1-1-million-cubans-have-received-at-least-one-dose-of-vaccine-candidates","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/over-1-1-million-cubans-have-received-at-least-one-dose-of-vaccine-candidates\/","title":{"rendered":"Over 1.1 million Cubans have received at least one dose of vaccine candidates"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Over 1.1 million doses of the vaccine candidates Soberana 02 and CIGB-66 (Abdala) were applied in Cuba, to date, as part of clinical trials, intervention study and health intervention in at-risk groups and territories.<\/p>\n\n\n\n

Iliana Morales, director of Science and Technological Innovation of the Ministry of Public Health (Minsap), said that 172,233 of them included the trials developed in several municipalities of Havana and Granma, Santiago de Cuba and Guant\u00e1namo, in the southeastern part of the country.<\/p>\n\n\n\n

The doctor added that 330,726 doses are accounted for in the intervention study on health personnel and the biopharmaceutical sector, extended to several localities of the island, while 612,376 correspond to the health intervention in groups and territories at risk, announced in recent days by Jos\u00e9 \u00c1ngel Portal, head of the Minsap.<\/p>\n\n\n\n

He said that in more than 60 percent of the nation’s clinical sites the inoculation of at least the first dose of the two most advanced anti-COVID-19 vaccine candidates of the five developed by the Cuban scientific community was concluded.<\/p>\n\n\n\n

Morales asserted the maintenance of the periods set by the highest health authority in the country for the interventions, but warned that no immunization site will open without the availability of the required material and human resources because the process will not stop once it has begun.
In this sense, she acknowledged the work of scientists, the Cuban biopharmaceutical industry, the health system, transporters and all the personnel who in one way or another contribute to the success of vaccination in its different variants.<\/p>\n\n\n\n

Incidentally, she commented on the existence of similarities and differences between the types of studies and interventions that aim, at the end of the day, at protection with their own vaccines against disease caused by the SARS-Cov-2 virus.<\/p>\n\n\n\n

She pointed out, as points in common, compliance with approved ethical standards – principle of voluntariness and informed consent of the participants – and controlled by the Research Ethics Committees, the fact of having methodological procedures for their organization and with a schedule and assurance plan.<\/p>\n\n\n\n

The protocols, inclusion and exclusion criteria, and the complexity of the data and its statistical processing differentiate them, although it was agreed to maintain the last aspect for all of them, given the traceability and reliability that it grants them, she pointed out.<\/p>\n\n\n\n

The Minsap official emphasized Cuba’s adherence to the requirements established by the national and international regulatory authorities for research of this magnitude, as it began with the clinical trials in their three phases, in order to demonstrate safety, immunogenicity and efficacy.
These were followed by intervention and health intervention studies, after the first two indicators had been proven.<\/p>\n\n\n\n

Iliana Morales underlined the challenge that the latter constitutes for family doctors and nurses, who have become the protagonists of one of the greatest feats of the Cuban health system: the fight against the new coronavirus.<\/p>\n\n\n\n

She added that the anti-COVID-19 vaccination does not imply the suspension of the rest of the programs, such as the anti-vectorial campaign and mother and child care, of vital importance in the preservation of the citizens’ health.
Finally, she insisted that the health intervention is expected to affect the population groups and territories with the highest epidemiological risk in Havana, Matanzas, Pinar del R\u00edo and Santiago de Cuba, in principle, until the whole island is covered.<\/p>\n\n\n\n

Source: CubaSi<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Over 1.1 million doses of the vaccine candidates Soberana 02 and CIGB-66 (Abdala) were applied in Cuba, to date, as part of clinical trials, intervention […]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":4391,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[8],"tags":[],"class_list":["post-4390","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cuba"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":4663,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-vaccination-in-havana-to-reach-all-areas-in-mid-june\/","url_meta":{"origin":4390,"position":0},"title":"Cuba: Vaccination in Havana To Reach All Areas in Mid-June","author":"Editorial Team","date":"June 9, 2021","format":false,"excerpt":"Given the complex epidemiological situation in Havana, it was decided to extend to all its municipalities; as of the second half of June, the sanitary intervention with the three doses of the Abdala vaccine candidate is currently being applied in at-risk groups and territories of the capital. The information was\u2026","rel":"","context":"In "Cuba"","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana.jpeg?fit=1200%2C801&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana.jpeg?fit=1200%2C801&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana.jpeg?fit=1200%2C801&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana.jpeg?fit=1200%2C801&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana.jpeg?fit=1200%2C801&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":4100,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-one-step-away-from-achieving-the-first-latin-american-vaccine-against-covid-19\/","url_meta":{"origin":4390,"position":1},"title":"Cuba, one step away from achieving the first Latin American vaccine against Covid-19","author":"Editorial Team","date":"April 22, 2021","format":false,"excerpt":"By\u00a0Mauricio Vicent They are called Soberana 02 and Abdala, and they are the two Cuban vaccine candidates against covid-19 that have gone the furthest in their development. Both are in phase 3 \u2014 the last before approval \u2014 of clinical trials. If everything goes as Cuban scientists hope, before the\u2026","rel":"","context":"In "Cuba"","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3542,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-will-produce-100-million-doses-of-its-covid-19-vaccine\/","url_meta":{"origin":4390,"position":2},"title":"Cuba will produce 100 million doses of Its Covid-19 vaccine","author":"Editorial Team","date":"January 21, 2021","format":false,"excerpt":"This year, Cuba will produce 100 million doses of its new Soberana\u00a002 coronavirus vaccine\u00a0to\u00a0meet its\u00a0internal demand and those of other countries, a leading\u00a0Cuban scientist reported on Wednesday. We are reorganizing our production capacities because we really have a lot of demand for the vaccine and we have to prepare ourselves,\"\u2026","rel":"","context":"In "Featured"","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuba-vaccine.jpg?fit=713%2C453&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuba-vaccine.jpg?fit=713%2C453&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuba-vaccine.jpg?fit=713%2C453&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuba-vaccine.jpg?fit=713%2C453&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3251,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-has-four-vaccine-candidates-against-covid-19-on-clinical-trials\/","url_meta":{"origin":4390,"position":3},"title":"Cuba has four vaccine candidates against Covid-19 on clinical trials","author":"Editorial Team","date":"November 27, 2020","format":false,"excerpt":"Cuba has registered four vaccine candidates against Covid-19 that are currently on clinical trials, after Mambisa and Abdala, developed by the Genetic Engineering and Biotechnology Center (CIGB), were authorized for this phase of the study.According to information released on social networks, the regulatory entity of Medicines, Equipment and Medical Devices\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":4010,"url":"https:\/\/www.cubasupport.ie\/latest\/washington-post-against-the-odds-cuba-could-become-a-coronavirus-vaccine-powerhouse\/","url_meta":{"origin":4390,"position":4},"title":"Washington Post: Against the odds, Cuba could become a coronavirus vaccine powerhouse","author":"Editorial Team","date":"March 30, 2021","format":false,"excerpt":"The Washington Post recalled on Monday how the efforts led by Cuban leader Fidel Castro to develop biotechnology on the island in the early 1980s, 40 years later, have placed Cuba before the possibility of becoming the world's smallest country to develop not just one, but multiple coronavirus vaccines. In\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/washington-post.png?fit=766%2C421&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/washington-post.png?fit=766%2C421&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/washington-post.png?fit=766%2C421&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/washington-post.png?fit=766%2C421&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2972,"url":"https:\/\/www.cubasupport.ie\/latest\/sovereign-2-closer-to-starting-clinical-trials\/","url_meta":{"origin":4390,"position":5},"title":"Sovereign 2, closer to starting clinical trials","author":"Editorial Team","date":"October 20, 2020","format":false,"excerpt":"Doctor of Science Vicente V\u00e9rez Bencomo, general director of the Finlay Vaccine Institute, belonging to the BioCubaFarma Business Group, affirmed in an interview with Granma that the so-called Sovereign 2 is an innovative vaccine, as it has no precedent among all those that are developed to face COVID-19 in the\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-18O","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdala-vacunacion1_0.jpg?fit=766%2C421&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/4390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=4390"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/4390\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/4391"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=4390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=4390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=4390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}